Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.55% |
| 2 | Consumer Discretionary | 0.95% |
| 3 | Financials | 0.77% |
| 4 | Healthcare | 0.67% |
| 5 | Industrials | 0.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
PUT
iShares MSCI Brazil ETF
EWZ
$8.52B
| $258M | 0.04% |
9,979,300
-4,794,200
| -32% | -$119M |
|
327
CALL
Agnico Eagle Mines
AEM
$109B
| $254M | 0.04% |
2,341,100
+87,400
| +4% | +$8.36M |
|
328
PUT
Cameco
CCJ
$44.6B
| $253M | 0.04% |
6,146,100
+3,263,100
| +113% | +$154M |
|
329
CALL
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
| $252M | 0.04% |
1,456,400
-499,500
| -26% | -$88.8M |
|
330
PUT
Newmont
NEM
$139B
| $249M | 0.04% |
5,154,900
-116,100
| -2% | -$5.1M |
|
331
CALL
Regeneron Pharmaceuticals
REGN
$85.9B
| $247M | 0.04% |
389,800
+17,900
| +5% | +$12.3M |
|
332
CALL
Constellation Energy
CEG
$96.7B
| $247M | 0.04% |
1,223,100
+495,800
| +68% | +$133M |
|
333
CALL
Marriott International
MAR
$92.9B
| $246M | 0.04% |
1,033,500
-171,600
| -14% | -$46.6M |
|
334
Strategy Inc
MSTR
$47.4B
| $246M | 0.04% |
851,738
-202,775
| -19% | -$64.4M |
|
335
PUT
Capital One
COF
$134B
| $245M | 0.04% |
1,366,300
+253,700
| +23% | +$47.9M |
|
336
PUT
State Street SPDR S&P Biotech ETF
XBI
$11.2B
| $243M | 0.04% |
3,000,900
-158,600
| -5% | -$14.2M |
|
|
X
337
CALL
DELISTED
US Steel
X
| $242M | 0.04% |
5,728,800
+1,198,100
| +26% | +$45.3M |
|
338
CALL
Dollar Tree
DLTR
$25.3B
| $241M | 0.04% |
3,213,600
+406,800
| +14% | +$29.1M |
|
339
CALL
Gilead Sciences
GILD
$181B
| $240M | 0.04% |
2,142,300
-193,000
| -8% | -$19.9M |
|
|
340
CALL
Capital One
COF
$134B
| $239M | 0.04% |
1,332,600
+693,700
| +109% | +$131M |
|
341
CALL
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.9B
| $239M | 0.04% |
447,700
+98,000
| +28% | +$55.6M |
|
342
Netflix
NFLX
$331B
| $237M | 0.04% |
2,539,240
-781,250
| -24% | -$74.3M |
|
343
Robinhood
HOOD
$97.2B
| $235M | 0.04% |
5,639,239
+4,562,088
| +424% | +$217M |
|
344
PUT
AT&T
T
$173B
| $234M | 0.04% |
8,279,400
-93,600
| -1% | -$2.35M |
|
345
CALL
Boston Scientific
BSX
$73B
| $233M | 0.04% |
2,310,100
-549,100
| -19% | -$55.3M |
|
346
CALL
Vertex Pharmaceuticals
VRTX
$139B
| $233M | 0.04% |
480,400
+13,100
| +3% | +$6.1M |
|
347
PUT
Philip Morris
PM
$293B
| $232M | 0.04% |
1,464,500
-258,100
| -15% | -$36.6M |
|
|
348
CALL
iShares MSCI Brazil ETF
EWZ
$8.52B
| $232M | 0.04% |
8,959,900
+2,259,200
| +34% | +$56.3M |
|
349
PUT
Honeywell
HON
$68.4B
| $230M | 0.04% |
1,152,564
-552,887
| -32% | -$112M |
|
350
State Street Energy Select Sector SPDR ETF
XLE
$41.7B
| $230M | 0.04% |
4,911,868
+2,747,780
| +127% | +$124M |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass withdrew a net $24.4B in Q1 2025, closing 1,483 positions and reducing 4,842 holdings. Its most notable exit was Inari Medical, Inc. Common Stock, an estimated $24M position sold in full.
By sector, the portfolio is most concentrated in Technology at 1.6% of assets, down from 2% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jeff Yass opened a new position in Brookfield Asset Management worth $86M.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,483 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.